A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Determine the effect of the lipid peroxidation end product (4-Hydroxynonenal) in the context of atherogenic among COVID-19 cases
2022
International Journal of Health Sciences
Coronavirus disease 2019 (COVID-19) manifests as multiple clinical and pathological organ dysfunctions. It also disrupts metabolic profile due to the release of pro-inflammatory cytokines causing a systemic inflammation reaction. As the number of COVID-19 complications continues to rise worldwide, the identification of risk factors for the disease is an urgent issue, and it remains controversial whether atherogenic lipid-related traits including lipid peroxidation product 4-Hydroxynonenal and
doi:10.53730/ijhs.v6ns7.12685
fatcat:zff5u4z4kncs5a7byqm7yvl5lq